Healthcare Utilization and Costs Reduction after Radiofrequency Ablation for Atrial Fibrillation in the Brazilian Private Healthcare System.
作者信息
Sarabanda Alvaro
机构信息
Instituto de Cardiologia do Distrito Federal, Brasília, DF - Brazil.
出版信息
Arq Bras Cardiol. 2019 Sep 2;113(2):258-259. doi: 10.5935/abc.20190148.
Abstract
摘要
相似文献
1
Healthcare Utilization and Costs Reduction after Radiofrequency Ablation for Atrial Fibrillation in the Brazilian Private Healthcare System.巴西私立医疗体系中房颤射频消融术后的医疗利用及成本降低情况
Arq Bras Cardiol. 2019 Sep 2;113(2):258-259. doi: 10.5935/abc.20190148.
2
Healthcare Utilization and Costs Reduction after Radiofrequency Ablation For Atrial Fibrillation in the Brazilian Private Healthcare System.巴西私立医疗体系中射频消融治疗心房颤动后的医疗利用和成本降低
Arq Bras Cardiol. 2019 Jul 29;113(2):252-257. doi: 10.5935/abc.20190139.
3
The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.冷冻球囊与射频消融治疗阵发性心房颤动对医疗资源利用和成本的影响：来自FIRE AND ICE试验的经济分析
J Am Heart Assoc. 2017 Jul 27;6(8):e006043. doi: 10.1161/JAHA.117.006043.
4
Cost analysis of radiofrequency catheter ablation for atrial fibrillation.射频导管消融治疗心房颤动的成本分析。
Int J Cardiol. 2013 Sep 10;167(6):2462-7. doi: 10.1016/j.ijcard.2013.01.028. Epub 2013 Feb 12.
5
Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System.巴西公共医疗系统中冷冻消融与射频消融治疗心房颤动的预算影响
Value Health Reg Issues. 2019 Dec;20:149-153. doi: 10.1016/j.vhri.2019.05.004. Epub 2019 Aug 21.
6
Urgent catheter ablation for treatment refractory symptomatic atrial fibrillation: Health care utilization and outcomes.急诊导管消融治疗难治性症状性心房颤动：医疗资源利用及结局
Heart Rhythm. 2022 Jul;19(7):1208-1209. doi: 10.1016/j.hrthm.2022.03.012. Epub 2022 Apr 28.
7
Diagnosis and ablation of atypical atrial tachycardia and flutter complicating atrial fibrillation ablation.诊断和消融治疗伴发于房颤消融的非典型房性心动过速和房扑。
Heart Rhythm. 2009 Aug;6(8 Suppl):S29-32. doi: 10.1016/j.hrthm.2009.02.011. Epub 2009 Feb 12.
8
Atrial-oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists.经皮射频导管消融房颤后发生心房食管瘘：风险依然存在。
Europace. 2017 Feb 1;19(2):250-258. doi: 10.1093/europace/euw284.
9
Successful catheter ablation of atrial fibrillation.心房颤动的成功导管消融
J Cardiovasc Electrophysiol. 1994 Dec;5(12):1045-52. doi: 10.1111/j.1540-8167.1994.tb01146.x.
10
[Catheter ablation of atrial flutter and paroxysmal atrial fibrillation].[心房扑动与阵发性心房颤动的导管消融术]
Arch Cardiol Mex. 2003 Apr-Jun;73 Suppl 1:S88-92.
本文引用的文献
1
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者死亡率、卒中和出血及心搏骤停的影响：CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.
2
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与药物治疗对心房颤动患者生活质量的影响：CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1275-1285. doi: 10.1001/jama.2019.0692.
3
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
4
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017年心房颤动导管消融与外科消融治疗专家共识声明：由心律学会（HRS）、欧洲心律协会（EHRA）、欧洲心血管病预防与康复协会（ECAS）、亚太心律学会（APHRS）及拉丁美洲心脏学会（SOLAECE）联合发布
Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12.
5
Atrial fibrillation: prevalence in a large database of primary care patients in Brazil.心房颤动：巴西大型基层医疗患者数据库中的患病率。
Europace. 2015 Dec;17(12):1787-90. doi: 10.1093/europace/euv185. Epub 2015 Jun 7.
6
Global epidemiology of atrial fibrillation.心房颤动的全球流行病学。
Nat Rev Cardiol. 2014 Nov;11(11):639-54. doi: 10.1038/nrcardio.2014.118. Epub 2014 Aug 12.
7
Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.美国成年人群中心房颤动当前和未来的发病率和患病率估计。
Am J Cardiol. 2013 Oct 15;112(8):1142-7. doi: 10.1016/j.amjcard.2013.05.063. Epub 2013 Jul 4.
8
Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis.心房颤动导管消融术或抗心律失常药物治疗的健康结局：倾向匹配分析结果
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):171-81. doi: 10.1161/CIRCOUTCOMES.111.963108. Epub 2012 Feb 28.
9
Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.接受导管消融治疗的心房颤动患者的医疗利用和支出。
J Cardiovasc Electrophysiol. 2012 Jan;23(1):1-8. doi: 10.1111/j.1540-8167.2011.02130.x. Epub 2011 Jul 21.
10
Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.美国心房颤动患者总增量医疗保健成本的估算。
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):313-20. doi: 10.1161/CIRCOUTCOMES.110.958165. Epub 2011 May 3.
Zotero 插件